The Surge in AFRM Stock – What's Driving the Investor Interest?

This afternoon we watched Affirm rise 6.7% to a price of $33.43 per share. The Large-Cap Diversified Financial company is now trading -8.96% below its average target price of $36.72. Analysts have set target prices ranging from $20.0 to $65.0 per share for Affirm, and have given the stock an average rating of hold.

Affirm has an elevated short interest of 14.4%. The stock's short ratio, or the number of days needed for all shorts to cover their positions, is 6.08. The company's insiders own 4.83% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. 83.0% of Affirm shares are held by institutional investors, which indicates a high level of confidence in the stock.

Institutions Invested in Affirm

Date Reported Holder Percentage Shares Value
2024-03-31 Morgan Stanley 12% 30,569,187 $1,021,927,930
2024-03-31 Vanguard Group Inc 8% 20,823,803 $696,139,740
2024-03-31 Capital Research Global Investors 7% 19,419,985 $649,210,104
2024-03-31 Capital World Investors 7% 19,079,071 $637,813,349
2024-03-31 Baillie Gifford and Company 7% 18,732,407 $626,224,371
2024-03-31 Blackrock Inc. 4% 9,965,847 $333,158,268
2024-03-31 Shaw D.E. & Co., Inc. 3% 9,071,991 $303,276,661
2024-03-31 Geode Capital Management, LLC 1% 3,821,486 $127,752,278
2024-03-31 State Street Corporation 1% 3,760,116 $125,700,679
2024-03-31 Two Sigma Advisers, LP 1% 3,556,500 $118,893,796

For these reasons, we consider that the Affirm is the subject of mixed market sentiment.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.